Diabo, Mary A.
HRN: 06-70-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/22/2025
05/29/2025
IVTT
1.5g
Q8H
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes